Potential pharmacological control of the NF-κB pathway.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  TIPS - Trends in Pharmacological Sciences

• Publication date

  2009-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.tips.2009.03.004PMID 19446347
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NF-κB-related genetic diseases

  2015cited by this paper
• Development of an insect-cell-based assay for detection of kinase inhibition using NF-kappaB-inducing kinase as a paradigm.

  2009cited by this paper
• Histone deacetylase inhibitors: new hope for rheumatoid arthritis?

  2008cited by this paper
• The Two-Faced NF-κB in the Skin

  2008cited by this paper
• Nuclear factor-kappaB activation: from bench to bedside.

  2008cited by this paper
• An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models

  2008cited by this paper
• TNF: a master switch for inflammation to cancer.

  2008cited by this paper
• Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

  2008cited by this paper
• A novel effect of DNA methyltransferase and histone deacetylase inhibitors : NFκB inhibition in malignant myeloblasts

  2008cited by this paper
• Contradictory functions of NF-kappaB in liver physiology and cancer.

  2008cited by this paper
• Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways

  2008cited by this paper
• Salinosporamide A (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down-modulation of NF-kappaB regulated gene products.

  2007cited by this paper
• Nuclear Factor-jB Activation: From Bench to Bedside

  2007cited by this paper
• Integrating cell-signalling pathways with NF-κB and IKK function

  2007cited by this paper
• Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma

  2007cited by this paper
• IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.

  2007cited by this paper
• Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease

  2007cited by this paper
• Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.

  2007cited by this paper
• Nuclear factor-kappa B: from clone to clinic.

  2007cited by this paper
• Integrating cell-signalling pathways with NF-kappaB and IKK function.

  2007cited by this paper
• NF-kappaB inhibition: a double-edged sword in cancer?

  2006cited by this paper
• Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways

  2006cited by this paper
• MLN120B, a Novel IκB Kinase β Inhibitor, Blocks Multiple Myeloma Cell Growth In vitro and In vivo

  2006cited by this paper
• Introduction to NF-κB: players, pathways, perspectives

  2006cited by this paper
• NF-kappaB-related genetic diseases.

  2006cited by this paper
• Proteasome Inhibitors Induce Death but Activate NF-κB on Endometrial Carcinoma Cell Lines and Primary Culture Explants*

  2006cited by this paper
• Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival.

  2006cited by this paper
• MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.

  2006cited by this paper
• NF-kappaB and IKK as therapeutic targets in cancer.

  2006cited by this paper
• NF-κB inhibition: A double-edged sword in cancer?

  2006cited by this paper
• Inhibitors of NF-κB signaling: 785 and counting

  2006cited by this paper
• NFκB pathway: A good signaling paradigm and therapeutic target

  2006cited by this paper
• IκB kinase complexes: gateways to NF-κB activation and transcription

  2006cited by this paper
• NFkappaB pathway: a good signaling paradigm and therapeutic target.

  2006cited by this paper
• Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression.

  2006cited by this paper
• Introduction to NF-kappaB: players, pathways, perspectives.

  2006cited by this paper
• Inhibitors of NF-kappaB signaling: 785 and counting.

  2006cited by this paper
• Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression

  2006cited by this paper
• IkappaB kinase complexes: gateways to NF-kappaB activation and transcription.

  2006cited by this paper
• NF-κB and IKK as therapeutic targets in cancer

  2006cited by this paper
• Molecular targets of dietary agents for prevention and therapy of cancer.

  2006cited by this paper
• IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation.

  2005cited by this paper
• IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation

  2005cited by this paper
• Zebrafish IκB Kinase 1 Negatively Regulates NF-κB Activity

  2005cited by this paper
• Histone Deacetylase Inhibition Down-Regulates Cyclin D1 Transcription by Inhibiting Nuclear Factor-κB/p65 DNA Binding

  2005cited by this paper
• Potential therapeutic targets in the NF-kappaB pathway for Alzheimer's disease.

  2005cited by this paper
• Amelioration of acute inflammation by systemic administration of a cell-permeable peptide inhibitor of NF-kappaB activation.

  2005cited by this paper
• Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases?

  2005cited by this paper
• IKK/NF-κB signaling: balancing life and death – a new approach to cancer therapy

  2005cited by this paper
• IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy.

  2005cited by this paper
• Zebrafish IkappaB kinase 1 negatively regulates NF-kappaB activity.

  2005cited by this paper
• Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo

  2004cited by this paper
• The IKK NF-κB system: a treasure trove for drug development

  2004cited by this paper
• Rapamycin inhibits doxorubicin-induced NF-kappaB/Rel nuclear activity and enhances the apoptosis of melanoma cells.

  2004cited by this paper
• The IKK NF-kappa B system: a treasure trove for drug development.

  2004cited by this paper
• Characterization of NF-κΒ/IκΒ Proteins in Zebra Fish and Their Involvement in Notochord Development

  2004cited by this paper
• Inhibition of Inhibitor of Nuclear Factor-κB Phosphorylation Increases the Efficacy of Paclitaxel in in Vitro and in Vivo Ovarian Cancer Models

  2004cited by this paper
• The Akt pathway: molecular targets for anti-cancer drug development.

  2004cited by this paper
• Phase 2 study of arsenic trioxide in patients with relapsed or refractory multiple myeloma

  2004cited by this paper
• Characterization of NF-kappa B/I kappa B proteins in zebra fish and their involvement in notochord development.

  2004cited by this paper
• Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-κB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation

  2004cited by this paper
• Identification of a p65 Peptide That Selectively Inhibits NF-κ B Activation Induced by Various Inflammatory Stimuli and Its Role in Down-regulation of NF-κB-mediated Gene Expression and Up-regulation of Apoptosis*

  2004cited by this paper
• An intracellular targeted NLS peptide inhibitor of karyopherin α:NF-κB interactions

  2003cited by this paper
• Novel IKK inhibitors: beta-carbolines.

  2003cited by this paper
• Distinct Pathways for NF-κB Regulation Are Associated with Aberrant Macrophage IL-12 Production in Lupus- and Diabetes-Prone Mouse Strains1

  2003cited by this paper
• A hybrid peptide derived from cecropin-A and magainin-2 inhibits osteoclast differentiation.

  2003cited by this paper
• BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice.

  2003cited by this paper
• Transcriptional activation of the NF‐κB p65 subunit by mitogen‐ and stress‐activated protein kinase‐1 (MSK1)

  2003cited by this paper
• Decoy oligodeoxynucleotides targeting NF-kappaB transcription factors: induction of apoptosis in human primary osteoclasts.

  2003cited by this paper
• Novel IKK inhibitors: β-carbolines

  2003cited by this paper
• Advantages of the circular dumbbell decoy in gene therapy and studies of gene regulation.

  2003cited by this paper
• An intracellular targeted NLS peptide inhibitor of karyopherin alpha:NF-kappa B interactions.

  2003cited by this paper
• Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy.

  2003cited by this paper
• TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway.

  2003cited by this paper
• A Selective IKK-2 Inhibitor Blocks NF-κB-dependent Gene Expression in Interleukin-1β-stimulated Synovial Fibroblasts*

  2003cited by this paper
• TAK1 is Critical for IκB Kinase-mediated Activation of the NF-κB Pathway

  2003cited by this paper
• BMS-345541 Is a Highly Selective Inhibitor of IκB Kinase That Binds at an Allosteric Site of the Enzyme and Blocks NF-κB-dependent Transcription in Mice*

  2003cited by this paper
• Regulation of distinct biological activities of the NF-κB transcription factor complex by acetylation

  2003cited by this paper
• Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.

  2003cited by this paper
• TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases

  2003cited by this paper
• A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts.

  2003cited by this paper
• Proteasome inhibition: a novel approach to cancer therapy.

  2002cited by this paper
• Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma.

  2002cited by this paper
• RNA Interference Directed against Viral and Cellular Targets Inhibits Human Immunodeficiency Virus Type 1 Replication

  2002cited by this paper
• Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications.

  2002cited by this paper
• HSP90 as a new therapeutic target for cancer therapy: the story unfolds

  2002cited by this paper
• A novel pathway regulating the mammalian target of rapamycin (mTOR) signaling.

  2002cited by this paper
• Glucocorticoids: do we know how they work?

  2002cited by this paper
• Coming of age: anti-cytokine therapies.

  2002cited by this paper
• A Phase I study of CHS 828 in patients with solid tumor malignancy.

  2002cited by this paper
• NF-kappaB in neuronal plasticity and neurodegenerative disorders.

  2001cited by this paper
• Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity.

  2001cited by this paper
• TAT Fusion Proteins Containing Tyrosine 42-deleted IκBα Arrest Osteoclastogenesis*

  2001cited by this paper
• Proteasome inhibitors: from research tools to drug candidates.

  2001cited by this paper
• Duration of nuclear NF-kappaB action regulated by reversible acetylation.

  2001cited by this paper
• Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.

  2001cited by this paper
• Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation

  2001cited by this paper
• NF-κB in neuronal plasticity and neurodegenerative disorders

  2001cited by this paper
• Inhibition of NF-κB Activity by Thalidomide through Suppression of IκB Kinase Activity*

  2001cited by this paper
• Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.

  2000cited by this paper

• Curcumin and acute myeloid leukemia: a golden hope, updated insights

  2025cites this paper
• Disulfiram alone regulates the radiosensitivity of lung cancer through NF-κB pathway and regulates the immune microenvironment after radiotherapy by targeting PD-L1 through c-Myc

  2025cites this paper
• Resveratrol and Physical Activity: A Successful Combination for the Maintenance of Health and Wellbeing?

  2025cites this paper
• Mitochondrial outer membrane protein MTUS1/ATIP1 exerts antitumor effects through ROS-induced mitochondrial pyroptosis in head and neck squamous cell carcinoma

  2024cites this paper
• Heat-Killed Lactilactobacillus sakei WB2305 and Lactiplantibacillus plantarum WB2324 Inhibited LPS-Induced Inflammation in Human Airway Epithelial Cells

  2024cites this paper
• Moringin, an isothiocyanate modulates multiple cellular signalling molecules in breast cancer cells.

  2024cites this paper
• Regulating miRNAs Expression by Resveratrol: Novel Insights based on Molecular Mechanism and Strategies for Cancer Therapy.

  2023cites this paper
• Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: Molecular signaling pathway-based approaches and future perspectives.

  2023cites this paper
• Association between Nfr2, HO-1, NF-kB Expression, Plasma ADMA, and Oxidative Stress in Metabolic Syndrome

  2023cites this paper
• The chemoprotective potentials of alpha-lipoic acid against cisplatin-induced ototoxicity: A systematic review.

  2023cites this paper
• Modulatory properties of curcumin in cancer: A narrative review on the role of interferons

  2023cites this paper
• Recent update on the protective potentials of resveratrol against cisplatin-induced ototoxicity: a systematic review.

  2023cites this paper
• Curcumin Loaded onto Folic acid Carbon dots as a Potent drug Delivery System for Antibacterial and Anticancer Applications

  2023cites this paper
• Curcumin: The Golden Nutraceutical on the Road to Cancer Prevention and Therapeutics. A Clinical Perspective.

  2022cites this paper
• Pharmacological Facet of Curcuma longa: A Review

  2022cites this paper
• Recent Overview of Resveratrol’s Beneficial Effects and Its Nano-Delivery Systems

  2022cites this paper
• Transcriptome profiling in psoriasis: NB-UVB treatment-associated transcriptional changes and modulation of autoinflammation in perilesional skin in early-phase disease.

  2022cites this paper
• Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention

  2022cites this paper
• Resveratrol in cancer treatment with a focus on breast cancer.

  2022cites this paper
• In Vitro and In Vivo Cardioprotective Effects of Curcumin against Doxorubicin-Induced Cardiotoxicity: A Systematic Review

  2022cites this paper
• The cardioprotective effects of nano‐curcumin against doxorubicin‐induced cardiotoxicity: A systematic review

  2022cites this paper
• Bioinformatics and Network Pharmacology Identify the Therapeutic Role and Potential Mechanism of Melatonin in AD and Rosacea

  2021cites this paper
• MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancer

  2021cites this paper
• The anti-proliferative and apoptotic effects of curcumin on feline mammary gland tumor cells in vitro.

  2021cites this paper
• Celastrol inhibits the proliferation and induces apoptosis of colorectal cancer cells via downregulating NF-κB/COX-2 signaling pathways.

  2021cites this paper
• The Role of Curcumin in Cancer Treatment

  2021cites this paper
• Amelioratory effect of neoandrographolide on myocardial ischemic‐reperfusion injury by its anti‐inflammatory and anti‐apoptotic activities

  2021cites this paper
• The pharmacological basis of the curcumin nutraceutical uses: an update

  2021cites this paper
• Tat-CIAPIN1 protein prevents against cytokine-induced cytotoxicity in pancreatic RINm5F β-cells

  2021cites this paper
• Celastrol attenuates the remodeling of pulmonary vascular and right ventricular in monocrotaline-induced pulmonary arterial hypertension in rats.

  2021cites this paper
• Rationalizing the therapeutic potential of apigenin against cancer.

  2020cites this paper
• Selective mediation of ovarian cancer SKOV3 cells death by pristine carbon quantum dots/Cu2O composite through targeting matrix metalloproteinases, angiogenic cytokines and cytoskeleton

  2020cites this paper
• Identification of a novel 1,2 oxazine that can induce apoptosis by targeting NF-κB in hepatocellular carcinoma cells

  2020cites this paper
• FBXW7 in Cancer: What Has Been Unraveled Thus Far?

  2019cites this paper
• Molecular modulators of celastrol as the keystones for its diverse pharmacological activities.

  2019cites this paper
• Nurr1: A vital participant in the TLR4‐NF‐&kgr;B signal pathway stimulated by &agr;‐synuclein in BV‐2 cells

  2019cites this paper
• Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases

  2019cites this paper
• Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets.

  2019cites this paper
• Focus on Formononetin: Anticancer Potential and Molecular Targets

  2019cites this paper
• Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer

  2019cites this paper
• Formononetin Regulates Multiple Oncogenic Signaling Cascades and Enhances Sensitivity to Bortezomib in a Multiple Myeloma Mouse Model

  2019cites this paper
• Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells.

  2019cites this paper
• Curcumin and Cancer

  2019cites this paper
• Targeting NF-κB signaling pathway in cancer by dietary polyphenols

  2019cites this paper
• Identification of α-N-catenin as a novel tumor suppressor in neuroblastoma

  2019cites this paper
• Anti-cancer effects of oxymatrine are mediated through multiple molecular mechanism(s) in tumor models.

  2019cites this paper
• Pleiotropic Pharmacological Actions of Capsazepine, a Synthetic Analogue of Capsaicin, against Various Cancers and Inflammatory Diseases

  2019cites this paper
• Fangchinoline, a Bisbenzylisoquinoline Alkaloid can Modulate Cytokine-Impelled Apoptosis via the Dual Regulation of NF-κB and AP-1 Pathways

  2019cites this paper
• An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases

  2019cites this paper
• Gamma Radiation-Induced Disruption of Cellular Junctions in HUVECs Is Mediated through Affecting MAPK/NF-κB Inflammatory Pathways

  2019cites this paper
• An Investigation on the Therapeutic Potential of Butein, A Tretrahydroxychalcone Against Human Oral Squamous Cell Carcinoma

  2019cites this paper
• Transduced Tat-CIAPIN1 reduces the inflammatory response on LPS− and TPA-induced damages

  2019cites this paper
• Casticin-Induced Inhibition of Cell Growth and Survival Are Mediated through the Dual Modulation of Akt/mTOR Signaling Cascade

  2019cites this paper
• Antiviral potential of curcumin

  2018cites this paper
• Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights

  2018cites this paper
• Natural cyclopeptide RA-V inhibits the NF-κB signaling pathway by targeting TAK1

  2018cites this paper
• Ophiopogonin D modulates multiple oncogenic signaling pathways, leading to suppression of proliferation and chemosensitization of human lung cancer cells.

  2018cites this paper
• The Application of Embelin for Cancer Prevention and Therapy †

  2018cites this paper
• Novel 1,3,4-Oxadiazole Induces Anticancer Activity by Targeting NF-κB in Hepatocellular Carcinoma Cells

  2018cites this paper
• Immune senescence, epigenetics and autoimmunity.

  2018cites this paper
• Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy

  2018cites this paper
• IFN-γ Induces Gastric Cancer Cell Proliferation and Metastasis Through Upregulation of Integrin β3-Mediated NF-κB Signaling

  2018cites this paper
• ROLE OF P65 AND P53 EXPRESSION IN DIFFERENT STAGE AND GRADE OF OVARIAN CANCER

  2018cites this paper
• Role of Celastrol in Chemosensitization of Cancer

  2018cites this paper
• Pharmacological Utilization of Bergamottin, Derived from Grapefruits, in Cancer Prevention and Therapy

  2018cites this paper
• Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis

  2018cites this paper
• N-Substituted Pyrido-1,4-Oxazin-3-Ones Induce Apoptosis of Hepatocellular Carcinoma Cells by Targeting NF-κB Signaling Pathway

  2018cites this paper
• Oleuropein induces apoptosis via abrogating NF‐κB activation cascade in estrogen receptor–negative breast cancer cells

  2018cites this paper
• Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer

  2018cites this paper
• Evidence for the Involvement of the Master Transcription Factor NF-κB in Cancer Initiation and Progression

  2018influential citation
• Role of RNF20 in cancer development and progression – a comprehensive review

  2018cites this paper
• Genistein: Its role in metabolic diseases and cancer.

  2017cites this paper
• SREBP-1c as a molecular bridge between lipogenesis and cell cycle progression of clear cell renal carcinoma

  2017cites this paper
• Potential Protective Effects of Ursolic Acid against Gamma Irradiation-Induced Damage Are Mediated through the Modulation of Diverse Inflammatory Mediators

  2017cites this paper
• Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa Linn

  2017cites this paper
• Rumex dentatus Inhibits Cell Proliferation, Arrests Cell Cycle, and Induces Apoptosis in MDA-MB-231 Cells through Suppression of the NF-κB Pathway

  2017influential citation
• Convulxin, a C‐type lectin‐like protein, inhibits HCASMCs functions via WAD‐motif/integrin‐&agr;v interaction and NF‐&kgr;B‐independent gene suppression of GRO and IL‐8

  2017cites this paper
• Molecular Targets of Ascochlorin and Its Derivatives for Cancer Therapy.

  2017cites this paper
• Potential role of an antimicrobial peptide, KLK in inhibiting lipopolysaccharide-induced macrophage inflammation

  2017cites this paper
• The Role of Resveratrol in Cancer Therapy

  2017cites this paper
• PROGNOSTICATION OF NF-ΚB AND P53 EXPRESSION IN DIFFERENT STAGE AND GRADE OF OVARIAN CANCER.

  2017cites this paper
• Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development

  2016cites this paper
• Curcumin: a Polyphenol with Molecular Targets for Cancer Control.

  2016cites this paper
• Aberrant lysine acetylation in tumorigenesis: Implications in the development of therapeutics.

  2016cites this paper
• New IKK inhibitors: Synthesis of new imidazo[1,2-a]quinoxaline derivatives using microwave assistance and biological evaluation as IKK inhibitors.

  2016cites this paper
• A novel 4,6-disubstituted-1,2,4-triazolo-1,3,4-thiadiazole derivative inhibits tumor cell invasion and potentiates the apoptotic effect of TNFα by abrogating NF-κB activation cascade

  2016cites this paper
• Aronia melanocarpa Concentrate Ameliorates Pro-Inflammatory Responses in HaCaT Keratinocytes and 12-O-Tetradecanoylphorbol-13-Acetate-Induced Ear Edema in Mice

  2016cites this paper
• Pomolic Acid Inhibits Invasion of Breast Cancer Cells Through the Suppression of CXC Chemokine Receptor Type 4 Expression

  2016cites this paper
• Aberrant nuclear factor-kappa B activity in acute myeloid Leukemia: from molecular pathogenesis to therapeutic target

  2015cites this paper
• Oxidative stress, redox homeostasis and NF-κB signaling in neurodegeneration

  2015cites this paper
• Geraniol attenuates 2-acetylaminofluorene induced oxidative stress, inflammation and apoptosis in the liver of wistar rats

  2015cites this paper
• The antidiabetic compound 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from averrhoa carambola L., demonstrates significant antitumor potential against human breast cancer cells

  2015cites this paper
• Small molecular inhibitors for the treatment of rheumatoid arthritis: progress so far.

  2015cites this paper
• Curcumin-induced downregulation of Axl receptor tyrosine kinase inhibits cell proliferation and circumvents chemoresistance in non-small lung cancer cells.

  2015cites this paper
• NF-κB in cancer therapy

  2015cites this paper
• Effect of CK2 Inhibitor in Caerulein Induced Acute Pancreatitis in a Mouse Model

  2015cites this paper
• Analysis of the intricate relationship between chronic inflammation and cancer.

  2015cites this paper
• Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers

  2015cites this paper
• Isorhamnetin augments the anti-tumor effect of capecitabine through the negative regulation of NF-κB signaling cascade in gastric cancer.

  2015cites this paper
• The Multifaceted Role of Curcumin in Cancer Prevention and Treatment

  2015cites this paper